Utilize our highly specialized, award-winning program to develop and share aggregate trial results summaries with study participants and the general public.
According to CISCRP’s 2019 Perceptions & Insights Study, both participants of clinical trials and those who have never participated agree that access to supporting information about clinical trials is a top priority.2
Per the CISCRP survey, 85% of respondents who had participated in a clinical trial reported that it is “somewhat important” or “very important” to receive a summary of the results of the clinical trial. However, the majority (61%) reported that they did not receive any reports or updates on the results of their trial once they completed their participation. 39% reported they never even heard back from anyone after the trial was over.
of participants did not receive any reports on the results of their trial
Prior to reviewing one of our lay language summaries, only 11% of participants understood basic facts about the trial (such as why the research had been conducted).3 After independently reviewing one of our lay language summaries, 91% of trial participants felt they understood the trial result communications “very well” or “somewhat well.”
We collaborate and consult extensively with research sponsors to ensure their results communications are understandable, meet applicable regulatory requirements, and follow current and emerging industry best practices.
Trial results summaries include all required elements for layperson summaries identified in Annex V of the 2014 EU Clinical Trials Regulation, which is necessary for a summary to be published in the EU database.
Consult with us to set up your trial results summary program.
Dominantly Inherited Alzheimer’s Disease Brochure
Expanded Registry Flyer (English)
Enfermedad de Alzheimer de herencia dominante
Expanded Registry Flyer (Spanish)
Forgetting the Little Things
Concerned About Memory Loss?
Click on the resources listed below to view the full versions of LCI’s materials.
Missy Hansen MSN, APRN, CPNP, CPHON, joined ICON in 2019 as a pediatric strategy liaison. She has 25+ years of experience as a pediatric nurse practitioner, including 17+ years in pediatric hematology/oncology at Children’s Minnesota, the largest hematology/oncology service line in the region, providing care for infants through young adults diagnosed with hematologic and/or oncology conditions. Ms. Hansen gained expertise working in inpatient, outpatient, and urgent care type settings. Ms. Hansen has in-depth experience working with the Children’s Oncology Group—the largest consortium with the most open pediatric studies around the world. She also has experience working with other consortia that conduct trials for pediatric to young adult patients.